Strata Skin Sciences, Inc. SSKN

0.01 0.00 0.00% as of 25 Sep
Market cap
$1.0M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
0.19 0.33 0.54 0.08 0.17 0.22 0.21 0.17 0.01 0.02
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 3.16 1.77 0.09 1.60
P/Operating CF
(24.52) 15.76 13.24 15.51 7.48 14.57 5.98 4.63 0.18 0.34
P/B ratio
2.02 2.23 1.43 0.13 0.20 0.19 0.23 0.16 0.02 0.03
Price to Tangible BV
0.00 0.00 0.00 0.00 0.77 0.47 0.56 0.40 0.00 0.00
EV/Sales
0.87 0.54 0.76 0.11 0.00 (0.46) (0.01) (0.13) 0.21 0.65
EV/EBITDA
0.00 0.00 0.00 3.19 0.00 63.89 0.00 0.00 1.15 3.68
EV/Operating CF
(9.57) 96.17 (49.11) (4.13) 0.04 (5.03) (0.14) (1.38) 1.57 62.24
EV/FCF
(6.27) (12.49) (4.60) (0.82) (0.03) 60.94 (0.15) (1.39) 1.71 67.26
Quick Ratio
0.45 1.03 1.03 0.84 1.25 1.12 1.15 2.31 0.69 1.19
Current Ratio
0.58 1.24 1.28 1.12 1.56 1.32 1.35 2.69 1.03 1.75
Net Debt/EBITDA
(97.86) (1.74) (2.70) 0.87 17.74 94.45 (3.51) (4.13) 1.09 3.60
Debt/Assets
50.29% 43.50% 35.81% 14.98% 16.39% 5.40% 18.30% 15.57% 26.17% 54.39%
Debt/Equity
5.28 3.06 1.19 0.36 0.30 0.10 0.30 0.24 0.52 1.60
Asset Turnover
0.94 0.87 0.71 0.73 0.64 0.49 0.67 0.69 0.77 0.66
Operating CF/Net income
0.45 (0.02) 0.05 0.17 (0.56) (0.48) (0.59) (0.72) (0.19) (0.10)
Capex/Depreciation
(0.32) (0.30) (0.83) (0.64) (0.89) (0.55) (0.02) 0.00 (0.04) 0.00
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(158.91%) (114.22%) (62.75%) (23.49%) (10.55%) (16.11%) (12.65%) (15.78%) (124.38%) (21.65%)
ROA
(19.13%) (26.22%) (22.97%) (11.23%) (5.80%) (9.34%) (7.99%) (9.31%) (52.27%) (7.15%)
ROIC
(28.40%) (50.00%) (27.42%) (12.71%) (13.44%) (24.71%) (8.67%) (9.46%) (4.32%) (6.56%)
Return on Tangible Assets
287.60% (76.06%) (71.50%) (47.94%) (19.26%) (38.14%) (32.99%) (20.27%) (269.53%) (22.54%)
Average Days of Receivables
49.00 57.13 48.58 45.13 41.80 46.54 50.68 41.48 36.09 40.30
Research and Development Expense of Revenue
1.37% 2.63% 3.95% 2.85% 4.78% 5.52% 3.17% 3.57% 5.39% 6.28%
Selling, General and Administrative Expense of Revenue
75.89% 69.50% 70.34% 70.21% 76.12% 73.35% 70.53% 65.01% 59.36% 64.28%
Intangible Assets out of Total Assets
0.16 0.19 0.33 0.50 0.41 0.32 0.35 0.39 0.53 0.51
Share Based Compensation of Revenue
2.09% 1.27% 3.91% 4.05% 5.48% 7.07% 3.78% 3.03% 0.59% 0.37%
Graham Net Nets
(2.05) (1.21) (0.76) (5.54) (0.24) 0.78 0.73 1.36 (24.85) (37.17)
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield
(111.90%) (92.44%) (59.62%) (193.21%) (51.20%) (86.67%) (61.50%) (79.19%) (5,690.48%) (688.89%)
Free Cash Flow Yield
(72.73%) (13.07%) (30.50%) (167.81%) (42.85%) (3.43%) 31.68% 56.61% 1,117.08% 62.50%
Revenue per Share
6.60 8.82 9.55 10.42 8.80 6.87 9.88 15.24 117.03 144.91
Operating CF per Share
(0.60) 0.05 (0.15) (0.27) 0.44 0.62 0.70 1.48 15.25 1.52
Capex per Share
(0.32) (0.43) (1.44) (1.08) (1.07) (0.64) (0.04) (0.01) (1.18) 0.00
Free Cash Flow per Share
(0.92) (0.38) (1.59) (1.34) (0.63) (0.02) 0.66 1.47 14.08 1.52
Cash per Share
1.70 2.26 2.32 1.96 3.70 5.39 4.89 8.42 14.99 18.54
Shareholders Equity per Share
0.63 1.31 3.63 6.29 7.46 7.70 8.96 15.95 73.25 69.46
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
0.63 1.31 3.63 6.29 7.46 7.70 8.96 15.95 73.25 69.46
Free Cash Flow
(4.26) (1.45) (5.54) (4.66) (2.14) (0.06) 2.11 2.88 3.82 0.32
Working Capital
(11.14) 3.20 3.37 1.63 7.17 5.99 6.12 14.60 0.28 4.62
Capital Expenditures
(1.47) (1.64) (5.02) (3.74) (3.65) (2.16) (0.11) (0.01) (0.32) (1.01)
Net Current Asset Value
(12.01) (13.36) (13.78) (15.39) (1.21) 3.95 4.87 6.95 (8.50) (17.72)
EV/EBIT
0.00 0.00 0.00 0.00 0.00 2.59 0.10 1.19 0.00 0.00
Capex to Sales
0.05 0.05 0.15 0.10 0.12 0.09 0.00 0.00 0.01 0.00
Net Profit Margin
(20.40%) (30.05%) (32.47%) (15.35%) (9.03%) (19.03%) (12.00%) (13.51%) (67.73%) (10.86%)
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.52 0.54 0.51 0.59 0.60 0.71 0.93 1.05 0.97 0.89
Cash ROIC
(44.93%) (34.33%) (34.30%) (29.83%) (11.78%) (7.38%) (5.93%) (4.36%) (10.42%) (23.39%)
Accounts Receivable Turnover
6.55 6.93 7.49 9.15 9.40 6.30 8.12 9.14 9.73 8.23
Accounts Payable Turnover
4.94 4.97 4.40 4.61 3.63 3.86 6.21 6.30 6.29 4.01
Inventory Turnover
5.07 5.83 5.17 4.37 2.92 2.77 3.89 4.39 4.46 3.64
Average Days of Payables
78.55 61.93 81.91 86.86 101.71 112.65 60.64 50.56 63.94 53.53
Days of Inventory on Hand
80.15 57.17 65.49 78.49 125.75 140.36 97.64 80.08 84.50 81.37
Average Receivables
4.69 4.85 4.46 3.95 3.19 3.67 3.89 3.27 3.27 3.73
Average Payables
2.60 2.89 3.38 3.12 2.79 2.32 1.82 2.02 2.07 3.15
Average Inventory
2.53 2.46 2.88 3.29 3.47 3.24 2.91 2.90 2.91 3.47
Average Assets
32.72 38.47 47.14 49.43 46.69 47.06 47.43 43.32 41.16 46.64
Average Common Equity
3.94 8.83 17.26 23.62 25.65 27.27 29.95 25.56 17.30 15.40

Fold the line items

Columns are period end dates